The fungicide Tebuconazole induces electromechanical cardiotoxicity in murine heart and human cardiomyocytes derived from induced pluripotent stem cells

Autor(es)

Santos-Miranda, Artur ; Joviano-Santos, V. Julliane ; Cruz-Nascimento, Taynara ; Neri, Elida Adalgisa ; Souza, Diego Santos ; Marques, Leisiane Pereira ; Krieger, Jose E. ; Roman-Campos, Danilo

• Tipo de documento: Artigo Científico
• Fonte: Toxicology Letters; v. 359, p. 10-pg., 2022-04-15.

Resumo

Tebuconazole (TEB) is an important fungicide that belongs to the triazole family. It is widely used in agriculture and its use has experienced a tremendous increase in the last decade. The long-term exposure of humans to this pesticide is a real threat because it is stable in water and soil. The association between long-term exposure to TEB and damage of several biological systems, including hepatotoxicity and cardiotoxicity is evident, however, acute toxicological studies to reveal the toxicity of TEB are limited. This research paper addressed the acute exposure of TEB in murine hearts, cardiomyocytes, and human cardiomyocytes derived from an induced pluripotent stem cell (hiPSC-CMs), spelling out TEB's impact on electromechanical properties of the cardiac tissue. In ex vivo experiments, TEB dose dependently, caused significant electrocardiogram (ECG) remodeling with prolonged PR and QTc interval duration. The TEB was also able to change the action potential waveform in murine cardiomyocytes and hiPSC-CMs. These effects were associated with the ability of the compound to block the L-type calcium current (IC50 = 33.2 +/- 7.4 mu mol.l(-1)) and total outward potassium current (IC50 = 5.7 +/- 1.5 mu mol.l(-1)). TEB also increased the sodium/calcium exchanger current in its forward and reverse modes. Additionally, sarcomere shortening and calcium transient in isolated cardiomyocytes were enhanced when cells were exposed to TEB at 30 mu mol.l(-1). Combined, our results demonstrated that acute TEB exposure affects the cardiomyocyte's electrocontractile properties and triggers the appearance of ECG abnormalities. (AU)

• Processo FAPESP: 18/22830-9 - Envolvimento do eixo de sinalização da proteína cinase II dependente de Ca2+-calmodulina (CaMKII) nas alterações elétricas e contráteis na fase crônica da doença de Chagas em modelo murino
• Beneficiário: Artur Santos Miranda
• Modalidade de apoio: Bolsas no Brasil - Pós-Doutorado
• Processo FAPESP: 19/18918-0 - Participação do óxido nítrico nas arritmias cardíacas durante o Hipotireoidismo
• Beneficiário: Diego Santos de Souza
• Modalidade de apoio: Bolsas no Brasil - Pós-Doutorado
• Processo FAPESP: 21/05584-7 - Avaliação da toxicidade aguda e crônica ao coração e ao cérebro expostos a pesticidas encontrados na água potável do Brasil
• Beneficiário: Danilo Roman Campos
• Modalidade de apoio: Auxílio à Pesquisa - Jovens Pesquisadores - Fase 2
• Processo FAPESP: 19/21304-4 - Mecanismos arritmogênicos em doenças do coração direito
• Beneficiário: Danilo Roman Campos
• Modalidade de apoio: Auxílio à Pesquisa - Regular
• Processo FAPESP: 20/14635-1 - Modelagem de doenças monogênicas para estudos fisiopatológicos e testes farmacológicos utilizando células especializadas derivadas de iPSCs
• Beneficiário: João Bosco Pesquero
• Modalidade de apoio: Auxílio à Pesquisa - Temático
• Processo FAPESP: 18/20777-3 - Variantes genéticas do canal para sódio Nav 1.5 e suas consequências terapêuticas
• Beneficiário: Julliane Vasconcelos Joviano dos Santos
• Modalidade de apoio: Bolsas no Brasil - Pós-Doutorado